Correlations between anti-EBV (left panel), anti-B19 (middle panel), anti-CMV (right panel) IgG levels and C-reactive protein (CPR) levels (A) and disease activity score (DAS28) (B) in all patients with RA (upper row), in ACPA-positive patients with RA (middle row) and in ACPA-negative patients with RA (lower row). (EPS 1848 kb
Receiver operating characteristic (ROC) curve analyses of anti-citrullinated peptides levels in RASF...
Table S1. Overview of medication used by all RA patients and by the subgroups of ACPA-positive and A...
Table S1. Matrix of ICC scores of three readers who contributed to the data; each MRI was evaluated ...
Prevalence of being positive for different combinations of anti-viral antibodies in RA, ACPA-positiv...
Disease activity at baseline in the rituximab database (IMAGE trial of early rheumatoid arthritis). ...
The levels of ACPA, HMGB1, S100A8/A9 in individual RASF samples from 40 patients with RA (Pat) and t...
Table S1. Disease characteristics (median values) in ACPA reactivity-positive versus reactivity-nega...
Methodological approach used to identify NI-0101 responder samples and biomarkers. RA patient strati...
Stratification of patients based on RF and anti-CCP titers at week 0. (PDF 419 kb
Correlations between platelet activation and markers of inflammation. Correlation between percentage...
The levels of ACPA, HMGB1 and S100A8/A9 in individual RASF samples pooled to create a single sample ...
Significant single nucleotide polymorphism (SNP) variants associated with anti-HCP1 positivity in pa...
Stimulation of IL-6 production by individual RASF samples and their response to NI-0101 treatment. T...
Illustration of a conditional inference tree for developing RA in pre-symptomatic individuals compar...
Figure S1. Gating strategy describing T-cell subsets. Figure S2. OPLS-DA score scatter plot showing ...
Receiver operating characteristic (ROC) curve analyses of anti-citrullinated peptides levels in RASF...
Table S1. Overview of medication used by all RA patients and by the subgroups of ACPA-positive and A...
Table S1. Matrix of ICC scores of three readers who contributed to the data; each MRI was evaluated ...
Prevalence of being positive for different combinations of anti-viral antibodies in RA, ACPA-positiv...
Disease activity at baseline in the rituximab database (IMAGE trial of early rheumatoid arthritis). ...
The levels of ACPA, HMGB1, S100A8/A9 in individual RASF samples from 40 patients with RA (Pat) and t...
Table S1. Disease characteristics (median values) in ACPA reactivity-positive versus reactivity-nega...
Methodological approach used to identify NI-0101 responder samples and biomarkers. RA patient strati...
Stratification of patients based on RF and anti-CCP titers at week 0. (PDF 419 kb
Correlations between platelet activation and markers of inflammation. Correlation between percentage...
The levels of ACPA, HMGB1 and S100A8/A9 in individual RASF samples pooled to create a single sample ...
Significant single nucleotide polymorphism (SNP) variants associated with anti-HCP1 positivity in pa...
Stimulation of IL-6 production by individual RASF samples and their response to NI-0101 treatment. T...
Illustration of a conditional inference tree for developing RA in pre-symptomatic individuals compar...
Figure S1. Gating strategy describing T-cell subsets. Figure S2. OPLS-DA score scatter plot showing ...
Receiver operating characteristic (ROC) curve analyses of anti-citrullinated peptides levels in RASF...
Table S1. Overview of medication used by all RA patients and by the subgroups of ACPA-positive and A...
Table S1. Matrix of ICC scores of three readers who contributed to the data; each MRI was evaluated ...